Home
Random
Nearby
Log in
Settings
Donate
About Wikidata
Disclaimers
Search
(Q34177359)
Watch
English
Antibody-DM1 conjugates as cancer therapeutics.
scientific article
In more languages
edit
Statements
instance of
scholarly article
1 reference
stated in
Europe PubMed Central
PMC publication ID
3105156
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21481526%20AND%20SRC:MED&resulttype=core&format=json
retrieved
28 January 2020
review article
1 reference
stated in
Europe PubMed Central
title
Antibody-DM1 conjugates as cancer therapeutics
(English)
1 reference
stated in
Europe PubMed Central
PMC publication ID
3105156
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21481526%20AND%20SRC:MED&resulttype=core&format=json
retrieved
28 January 2020
main subject
antibody
1 reference
based on heuristic
inferred from title
author
Manu Lopus
series ordinal
1
1 reference
stated in
Europe PubMed Central
PMC publication ID
3105156
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21481526%20AND%20SRC:MED&resulttype=core&format=json
retrieved
28 January 2020
author name string
Manu Lopus
series ordinal
1
1 reference
stated in
Europe PubMed Central
PubMed publication ID
21481526
retrieved
31 July 2017
language of work or name
English
0 references
publication date
9 April 2011
1 reference
stated in
Europe PubMed Central
PMC publication ID
3105156
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21481526%20AND%20SRC:MED&resulttype=core&format=json
retrieved
28 January 2020
published in
Cancer Letters
1 reference
stated in
Europe PubMed Central
PMC publication ID
3105156
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21481526%20AND%20SRC:MED&resulttype=core&format=json
retrieved
28 January 2020
volume
307
1 reference
stated in
Europe PubMed Central
PMC publication ID
3105156
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21481526%20AND%20SRC:MED&resulttype=core&format=json
retrieved
28 January 2020
issue
2
1 reference
stated in
Europe PubMed Central
PMC publication ID
3105156
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21481526%20AND%20SRC:MED&resulttype=core&format=json
retrieved
28 January 2020
page(s)
113-118
1 reference
stated in
Europe PubMed Central
PMC publication ID
3105156
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21481526%20AND%20SRC:MED&resulttype=core&format=json
retrieved
28 January 2020
cites work
HER2-positive breast cancer cells resistant to trastuzumab and lapatinib lose reliance upon HER2 and are sensitive to the multitargeted kinase inhibitor sorafenib
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3105156
retrieved
5 July 2018
A molecular and structural mechanism for G protein-mediated microtubule destabilization.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3105156
retrieved
5 July 2018
Maytansinoid-antibody conjugates induce mitotic arrest by suppressing microtubule dynamic instability.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3105156
retrieved
5 July 2018
Maytansine and cellular metabolites of antibody-maytansinoid conjugates strongly suppress microtubule dynamics by binding to microtubules
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3105156
retrieved
5 July 2018
Microtubule-binding agents: a dynamic field of cancer therapeutics
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3105156
retrieved
5 July 2018
Analysis of dynamic instability of steady-state microtubules in vitro by video-enhanced differential interference contrast microscopy with an appendix by Emin Oroudjev
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3105156
retrieved
5 July 2018
Antibody-maytansinoid conjugates designed to bypass multidrug resistance
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3105156
retrieved
5 July 2018
Antibody-maytansinoid conjugates for the treatment of myeloma
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3105156
retrieved
5 July 2018
Targeted cancer therapy: conferring specificity to cytotoxic drugs
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3105156
retrieved
5 July 2018
Trastuzumab--mechanism of action and use in clinical practice
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3105156
retrieved
5 July 2018
Semisynthetic maytansine analogues for the targeted treatment of cancer
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3105156
retrieved
5 July 2018
Antibody-drug conjugates designed to eradicate tumors with homogeneous and heterogeneous expression of the target antigen
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3105156
retrieved
5 July 2018
Drug-conjugated monoclonal antibodies for the treatment of cancer
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3105156
retrieved
5 July 2018
Microtubules as a target for anticancer drugs
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3105156
retrieved
5 July 2018
Recent developments in the maytansinoid antitumor agents
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3105156
retrieved
5 July 2018
Cantuzumab mertansine, a maytansinoid immunoconjugate directed to the CanAg antigen: a phase I, pharmacokinetic, and biologic correlative study
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3105156
retrieved
5 July 2018
Targeted delivery of chemotherapeutics: tumor-activated prodrug therapy
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3105156
retrieved
5 July 2018
Trastuzumab, a recombinant DNA-derived humanized monoclonal antibody, a novel agent for the treatment of metastatic breast cancer
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3105156
retrieved
5 July 2018
Eradication of large colon tumor xenografts by targeted delivery of maytansinoids
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3105156
retrieved
5 July 2018
Humanization of murine monoclonal antibodies through variable domain resurfacing
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3105156
retrieved
5 July 2018
Ep-CAM: a human epithelial antigen is a homophilic cell-cell adhesion molecule
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3105156
retrieved
5 July 2018
Phase II study of maytansine in the treatment of advanced or recurrent squamous cell carcinoma of the cervix. A Gynecologic Oncology Group study
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3105156
retrieved
5 July 2018
The linkage of cytotoxic drugs to monoclonal antibodies for the treatment of cancer
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3105156
retrieved
5 July 2018
Immunoconjugates containing novel maytansinoids: promising anticancer drugs
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3105156
retrieved
5 July 2018
Binding of maytansine to rat brain tubulin
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3105156
retrieved
5 July 2018
Maytansine binding to the vinblastine sites of tubulin
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3105156
retrieved
5 July 2018
Maytansine
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3105156
retrieved
5 July 2018
Maytansine: a phase I study of an ansa macrolide with antitumor activity
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3105156
retrieved
5 July 2018
Initial clinical trials of maytansine, an antitumor plant alkaloid
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3105156
retrieved
5 July 2018
Phase I study of maytansine using a 3-day schedule
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3105156
retrieved
5 July 2018
Trastuzumab-DM1: building a chemotherapy-free road in the treatment of human epidermal growth factor receptor 2-positive breast cancer.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3105156
retrieved
28 October 2018
Anti-CD22-MCC-DM1: an antibody-drug conjugate with a stable linker for the treatment of non-Hodgkin's lymphoma
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3105156
retrieved
28 October 2018
Phase I trial of the prostate-specific membrane antigen-directed immunoconjugate MLN2704 in patients with progressive metastatic castration-resistant prostate cancer
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3105156
retrieved
28 October 2018
Phase II evaluation of maytansine in patients with metastatic lung cancer
1 reference
stated in
PubMed
reference URL
https://pubmed.ncbi.nlm.nih.gov/21481526
retrieved
12 December 2020
based on heuristic
inferred from PubMed ID database lookup
Maytansine, a novel antileukemic ansa macrolide from Maytenus ovatus
1 reference
stated in
PubMed
reference URL
https://pubmed.ncbi.nlm.nih.gov/21481526
retrieved
12 December 2020
based on heuristic
inferred from PubMed ID database lookup
Phase II evaluation of dibromodulcitol, ICRF-159, and maytansine for sarcomas
1 reference
stated in
PubMed
reference URL
https://pubmed.ncbi.nlm.nih.gov/21481526
retrieved
12 December 2020
based on heuristic
inferred from PubMed ID database lookup
The maytansinoids. Isolation, structural elucidation, and chemical interrelation of novel ansa macrolides
1 reference
stated in
PubMed
reference URL
https://pubmed.ncbi.nlm.nih.gov/21481526
retrieved
12 December 2020
based on heuristic
inferred from PubMed ID database lookup
Cis-aconityl spacer between daunomycin and macromolecular carriers: A model of pH-sensitive linkage releasing drug from a lysosomotropic conjugate
1 reference
stated in
PubMed
reference URL
https://pubmed.ncbi.nlm.nih.gov/21481526
retrieved
12 December 2020
based on heuristic
inferred from PubMed ID database lookup
Phase II evaluation of maytansine in refractory non-Hodgkin's lymphoma: a Southwest Oncology Group study
1 reference
stated in
PubMed
reference URL
https://pubmed.ncbi.nlm.nih.gov/21481526
retrieved
12 December 2020
based on heuristic
inferred from PubMed ID database lookup
Identifiers
DOI
10.1016/J.CANLET.2011.03.017
1 reference
stated in
Europe PubMed Central
PMC publication ID
3105156
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21481526%20AND%20SRC:MED&resulttype=core&format=json
retrieved
28 January 2020
PMC publication ID
3105156
1 reference
stated in
Europe PubMed Central
PMC publication ID
3105156
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21481526%20AND%20SRC:MED&resulttype=core&format=json
retrieved
28 January 2020
PubMed publication ID
21481526
1 reference
stated in
Europe PubMed Central
PMC publication ID
3105156
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21481526%20AND%20SRC:MED&resulttype=core&format=json
retrieved
28 January 2020
ResearchGate publication ID
51040360
0 references
Sitelinks
Wikipedia
(0 entries)
edit
Wikibooks
(0 entries)
edit
Wikinews
(0 entries)
edit
Wikiquote
(0 entries)
edit
Wikisource
(0 entries)
edit
Wikiversity
(0 entries)
edit
Wikivoyage
(0 entries)
edit
Wiktionary
(0 entries)
edit
Multilingual sites
(0 entries)
edit